Lilly acquires Nexus Pharmaceuticals Kenosha County facility [Video]

Indiana-based pharmaceutical company Eli Lilly and Illinois-based sterile manufacturer Nexus Pharmaceuticals recently announced an agreement for Lilly to acquire a manufacturing facility from Nexus in Pleasant Prairie, 10300 128th Ave.

According to the company, the acquisition of the facility will “further expand Lilly’s global injectable product manufacturing network and support increased demand for the company’s medicines.”

Lilly estimates production at the local facility could begin at the end of 2025.

“The acquisition of this state-of-the-art facility underscores our unwavering commitment to growth and innovation, and we look forward to welcoming talented new Nexus colleagues to Lilly from the Pleasant Prairie facility,” said Edgardo Hernandez, executive vice president and president of Lilly manufacturing. “We are investing boldly to serve our patients, to meet product demand and to build capabilities for our robust pipeline of the future.”

Usman Ahmed, president and chief executive officer of Nexus, said they were excited Lilly was …